Evidence map›Paper›PMID 24880615›Full record

ArticleNature medicine2014

On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles.

Ekaterina Y Lukianova-Hleb, Xiaoyang Ren, Rupa R Sawant, Xiangwei Wu, Vladimir P Torchilin, Dmitri O Lapotko

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Direct measuring of single-heterogeneous bubble nucleation mediated by surface topology.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Synchronous Chemoradiation Nanovesicles by X-Ray Triggered Cascade of Drug Release.Angewandte Chemie (International ed. in English) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ekaterina Y Lukianova-HlebDepartment of Biochemistry and Cell Biology, Rice University, Houston, Texas, USA.
Xiaoyang Ren *Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rupa R Sawant *Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts, USA.
Xiangwei WuDepartment of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Vladimir P TorchilinCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts, USA.
Dmitri O LapotkoDepartment of Biochemistry and Cell Biology, Rice University, Houston, Texas, USA.
Northeastern University · USRice University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Physico-Chemical Nanocharacterization CoreU54CA151881 · NCI · NORTHEASTERN UNIVERSITY · PI GOLDBERG, S. NAHUM · 2010 to 2014
$12.4M
Surface-modified pharmaceutical nanocarriers for subcellular targetingR01CA128486 · NCI · NORTHEASTERN UNIVERSITY · PI TORCHILIN, VLADIMIR P · 2008 to 2012
$1.8M
Cell Theranostics with Tunable Plasmonic NanobubblesR01GM094816 · NIGMS · RICE UNIVERSITY · PI LAPOTKO, DMITRI · 2010 to 2013
$1.1M
Laser scanning confocal microscopeS10RR026399 · NCRR · RICE UNIVERSITY · PI BARTEL, BONNIE · 2010 to 2010
$500k
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA128486NCI NIH HHS R01CA128486NCI NIH HHS U54 CA151881NCRR NIH HHS S10 RR026399NCRR NIH HHS S10RR026399-01NIGMS NIH HHS R01 GM094816NIGMS NIH HHS R01GM094816
6 · The paper itself

Abstract

Chemoradiation-resistant cancers limit treatment efficacy and safety. We show here the cancer cell-specific, on-demand intracellular amplification of chemotherapy and chemoradiation therapy via gold nanoparticle- and laser pulse-induced mechanical intracellular impact. Cancer aggressiveness promotes the clustering of drug nanocarriers and gold nanoparticles in cancer cells. This cluster, upon exposure to a laser pulse, generates a plasmonic nanobubble, the mechanical explosion that destroys the host cancer cell or ejects the drug into its cytoplasm by disrupting the liposome and endosome. The same cluster locally amplifies external X-rays. Intracellular synergy of the mechanical impact of plasmonic nanobubble, ejected drug and amplified X-rays improves the efficacy of standard chemoradiation in resistant and aggressive head and neck cancer by 100-fold in vitro and 17-fold in vivo, reduces the effective entry doses of drugs and X-rays to 2-6% of their clinical doses and efficiently spares normal cells. The developed quadrapeutics technology combines four clinically validated components and transforms a standard macrotherapy into an intracellular on-demand theranostic microtreatment with radically amplified therapeutic efficacy and specificity.

Indexed as

NanostructuresAnimalsCarcinoma, Squamous CellCombined Modality TherapyDrug Resistance, NeoplasmHead and Neck NeoplasmsHumansMiceTreatment Outcome

Identifiers

PMID24880615
PMCPMC4271542
OpenAlexW1975914372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.